The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Technetium, as they called it, was the last of elements 1-92 to be tracked down, and in fact it had to be synthesized rather than isolated from naturally occurring sources.

Lantheus (NASDAQ:LNTH – Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, ...

DAR ES SALAAM: In recent years, Tanzania has emerged as a trailblazer in leveraging nuclear technologies to enhance its ...

Analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Lantheus in a research note issued on Tuesday, February 18th. Leerink Partnrs analyst R. Ruiz forecasts that the ...

Greg Piefer is a UW-Madison College of Engineering product who is bullish about fusion uses today while urging patience over ...

Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99m Tc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix’s ...

Isotopes Market There is an increasing trend in the use of rare stable isotopes, such as 13C, 15N, and 18O, as tracers in scientific resear ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been approved by the Danish ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...